Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma

Modern Pathology(2024)10.1016/j.modpat.2023.100420Source: DataRank Database

Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma is a research paper published in Modern Pathology (2024). On theSindex it has a DataRank of 0.442. It has been cited 18 times.

N/A

0.442DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: hybridTopics (18)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.442

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (18)

Jason C. Chang ORCID,Achim A. Jungbluth ORCID,Prasad S. Adusumilli ORCID,Francis M. Bodd ORCID,Denise Frosina

Live enrichment

PubMed:38185249 PMC:PMC11823465

National Cancer Institute

Grant: 2022

National Cancer Institute

Grant: P30 CA008748

U.S. Department of Defense

National Institutes of Health

Mesothelioma Applied Research Foundation

hybridLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.modpat.2023.100420

publisherhttps://api.elsevier.com/content/article/PII:S0893395223003253?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0893395223003253?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11823465

Europe_PMChttps://europepmc.org/articles/PMC11823465

MeSH Terms

HumansMesotheliomaPleural NeoplasmsUbiquitin ThiolesteraseImmunohistochemistryIn Situ Hybridization, FluorescenceSequence DeletionHomozygoteCyclin-Dependent Kinase Inhibitor p16High-Throughput Nucleotide SequencingBiomarkers, TumorMesothelioma, Malignant

Keywords

ImmunohistochemistryNext-generation SequencingCdkn2aMtap9P21 Homozygous DeletionDiffuse Pleural Mesothelioma